TCTMD

MitraClip Analysis Highlights Questions of Patient Selection in Functional MR

A new, retrospective study trying to tease out the benefits of MitraClip procedures according to the etiology of mitral regurgitation (MR) hints that, compared with conservative management, ...
MedPage Today

Post-MitraClip Gradients Not So Dangerous After All

Patients with secondary mitral regurgitation (MR) who were left with high gradients after a MitraClip procedure were not inherently at a disadvantage in their subsequent clinical outcomes, according ...
TCTMD

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Hospitals that perform a larger number of transcatheter mitral valve repairs (TMVRs) with the MitraClip (Abbott) have significantly better procedural success, as well as shorter procedural times and ...
Investing

Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results

Abbott Lifesciences (NYSE:ABT) recently announced favorable results from two distinctly-conducted analyses of the two-year long COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous ...
MedPage Today

MitraClip G4 Sets the Bar Higher for Transcatheter Edge-to-Edge Repair

BOSTON -- Contemporary practice had the fourth-generation MitraClip producing low short-term mortality and other good results even in mitral regurgitation (MR) patients previously deemed unsuitable ...
Medscape

COAPT Substudy Spotlights QOL Gains With MitraClip

NEW ORLEANS — To much acclaim, the COAPT trial demonstrated that use of the MitraClip (Abbott) in a very sick population with symptomatic (heart failure (HF) and secondary mitral regurgitation (MR) ...
Healio

COAPT: Benefits of MitraClip sustained to 5 years; death, HF events high

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Transcatheter mitral valve repair for patients with HF and severe secondary mitral regurgitation ...
Healio

First-in-class MitraClip receives FDA approval

Please provide your email address to receive an email when new articles are posted on . Abbott Vascular has announced today that its first-in-class, catheter-based MitraClip device has been approved ...
technologynetworks

Abbott's Minimally Invasive MitraClip® System for Mitral Regurgitation

Abbott has announced data from the EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) High Surgical Risk cohort evaluating the company's first-in-class catheter-based MitraClip® System for the ...
Nasdaq

Abbott's MitraClip G4 Receives CE Mark for Treatment of MR

Abbott Laboratories ABT recently received the CE Mark for its fourth-generation MitraClip Transcatheter Mitral Valve Repair (TMVR) System, MitraClip G4. It is a renowned minimally invasive mitral ...
MD&M East

Abbott Receives 9 Reports of MitraClip’s Delivery System Failing

On February 15, FDA announced that Abbott Vascular has received nine reports of its MitraClip delivery system failing to detach from the Clip, which resulted in the death of one patient and open-heart ...
Investing

Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results (Revised)

Abbott Laboratories (NYSE:ABT) recently announced favorable results from two distinctly-conducted analyses of the two-year long COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous ...